In addition, following treatment with iTAK1, the cell surface (Fig. 7B) and mRNA levels of cardiac hypertrophy markers (Fig. 7C) were very similar, despite GCN5 overexpression and PE stimulation. This evidence concerns the gene KAT2A and cardiac hypertrophy.